Human clearance prediction: shifting the paradigm
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
There is a growing momentum to use in vitro methods, nestled in in silico physiologically based pharmacokinetic models as the primary source of prediction of human clearance. This represents a shift in the paradigm for predictions in humans, which has been traditionally based on in vivo empirical approaches involving allometric scaling. For hepatic clearance of lipophilic metabolised compounds, methodology for scaling based on in vitro data is well established and approaches based on in vitro data alone seem to be the most accurate. However, limitations in in vitro methods exist for compounds cleared by other mechanisms, such as those for which active transport is a major determinant of the hepatobiliary and renal elimination processes. A major challenge for any clearance prediction is the assessment of variability and uncertainty. Integrative and mechanistic approaches such as physiologically based scaling provide the most promising way of dealing with these aspects. In this review, the authors assess advances in in vitro methods for hepatic and renal clearance predictions with particular emphasis on mechanistic approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obach, R. S. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)14938-0 · Cited by 1,232
The Prediction of Human Pharmacokinetic Parameters from Preclinical and in Vitro Metabolism Data
Obach, R. S., Baxter, J. G., Liston, T. E., Silber, B. M., Jones, B. C., Macintyre, F., Rance, D. J., & Wastall, P. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36999-x · Cited by 987
THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
Paine, M. F., Hart, H. L., Ludington, S. S., Haining, R. L., Rettie, A. E., & Zeldin, D. C. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.008672 · Cited by 870
Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data
Iwatsubo, T., Hirota, N., Ooie, T., Suzuki, H., Shimada, N., Chiba, K., Ishizaki, T., Green, C. E., Tyson, C. A., & Sugiyama, Y. (1997) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(96)00184-2 · Cited by 479
Barter, Z., Bayliss, M., Beaune, P., Boobis, A., Carlile, D., Edwards, R., Brian Houston, J., Lake, B., Lipscomb, J., Pelkonen, O., et al. (2007) · Current Drug Metabolism · doi:10.2174/138920007779315053 · Cited by 459 · cited 1×
“Microsomal recovery and hepatocellularity scaling factors have been reported in the literature for various species including humans [15].”
BackgroundMechanistic Approaches to Volume of Distribution Predictions: Understanding the Processes
Rodgers, T., & Rowland, M. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9210-3 · Cited by 420
Self-citationA Novel Strategy for Physiologically Based Predictions of Human Pharmacokinetics
Jones, H. M., Parrott, N., Jorga, K., & Lav??, T. (2006) · Clinical Pharmacokinetics · doi:10.2165/00003088-200645050-00006 · Cited by 352 · cited 2×
“With the continuing impetus to improve PK prediction further, strong interest has been sparked in the use of in vitro–in silico physiologically based PK (PBPK) models [1,6-9].”
BackgroundSelf-citationEVALUATION OF DRUG-DRUG INTERACTION IN THE HEPATOBILIARY AND RENAL TRANSPORT OF DRUGS
Shitara, Y., Sato, H., & Sugiyama, Y. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121444 · Cited by 336 · cited 1×
“Such approaches have been reported by Shitara et al. (2005) [47], Poirier et al. (2008) [48] and Paine et al. (2008) [49].”
BackgroundHosea, N. A., Collard, W. T., Cole, S., Maurer, T. S., Fang, R. X., Jones, H., Kakar, S. M., Nakai, Y., Smith, B. J., Webster, R., et al. (2009) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009333209 · Cited by 300
De Buck, S. S., Sinha, V. K., Fenu, L. A., Nijsen, M. J., Mackie, C. E., & Gilissen, R. A. H. J. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.015644 · Cited by 256 · cited 1×
“With the continuing impetus to improve PK prediction further, strong interest has been sparked in the use of in vitro–in silico physiologically based PK (PBPK) models [1,6-9].”
Background
Cited by
Physiologically-Based Pharmacokinetics in Drug Development and Regulatory Science
Rowland, M., Peck, C., & Tucker, G. (2011) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010510-100540 · Cited by 662
Self-citationZhao, P., Zhang, L., Grillo, J. A., Liu, Q., Bullock, J. M., Moon, Y. J., Song, P., Brar, S. S., Madabushi, R., Wu, T. C., et al. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.298 · Cited by 522
Davies, M., Jones, R. D. O., Grime, K., Jansson-Löfmark, R., Fretland, A. J., Winiwarter, S., Morgan, P., & McGinnity, D. F. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.03.004 · Cited by 123
Lombardo, F., Waters, N. J., Argikar, U. A., Dennehy, M. K., Zhan, J., Gunduz, M., Harriman, S. P., Berellini, G., Liric Rajlic, I., & Obach, R. S. (2013) · The Journal of Clinical Pharmacology · doi:10.1177/0091270012440282 · Cited by 106
“The different approaches employed for prediction of human clearance, along with their assumptions and limitations, have been discussed in recent reviews.(14,15) Nevertheless, a more detailed retrospective analysis of microdosing, based on 18 compounds, showed that accuracy against a pharmacological dose PK was achieva…”
MethodSystems Biology, Systems Medicine, Systems Pharmacology: The What and The Why
Stéphanou, A., Fanchon, E., Innominato, P. F., & Ballesta, A. (2018) · Acta Biotheoretica · doi:10.1007/s10441-018-9330-2 · Cited by 50
Metadata
- Authors
- Lavé, T., Chapman, K., Goldsmith, P., & Rowland, M.
- Venue
- Expert Opinion on Drug Metabolism & Toxicology
- Publisher
- Informa UK Limited
- Published
- 2009-07-17
- Volume
- 5
- Issue
- 9
- Pages
- 1039-1048
- ISSN
- 1742-5255 (ISSN-L)
- 1744-7607
- OpenAlex
- W2066763741
- Cited by
- 50
- References
- 17
- FWCI
- 4.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Human clearance prediction: shifting the paradigm. https://app.cochat.ai/papers/10.1517/17425250903099649
- The paper
- Lavé, T., Chapman, K., Goldsmith, P., & Rowland, M. (2009). Human clearance prediction: shifting the paradigm. Expert Opinion on Drug Metabolism & Toxicology. https://doi.org/10.1517/17425250903099649
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.